Company intelligence / Profile preview

nuWay

Switzerland

Ownership: Private
Development stage: Other

Overview

nuWay is a healthcare technology company focused on data-driven software for the hospital supply chain rather than therapeutic drug development. Its core product, nuMetrix, is a cloud-based SaaS platform that applies big data, algorithms, and machine learning to help healthcare providers improve purchasing, logistics, savings, and operational performance. The company appears to operate in the digital health and healthcare operations space, serving hospitals and health systems in Europe. Based on the available information, nuWay is not a biotech or pharma developer and does not appear to maintain a traditional therapeutic pipeline.

Industry: Biomedical IT and Biomedical Data Platforms

Beyond the preview

Go deeper on nuWay.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on nuWay.

Explore the full profile